AJANTPHARMAjanta Pharma Limited
Convert to ideaPharmaceuticals & Biotechnology · Pharmaceuticals
The verdict combines business quality, price and timing. Sign in free to see it.
Sign in freeUp 0.9 this quarter.
Momentum from moving averages, Supertrend and RSI.
1 forensic issue found. Sign in to see which.
Valuation Metrics
Q2 FY2027Intrinsic value, Graham number and DCF against today's price
1 found · risk minor
Quality, growth, balance sheet and earnings quality behind the score
ⓘ Based on fundamental & forensic analysis. Always verify against official filings and consult a financial advisor.
Financial Metrics
Comparing Q2 FY2027 vs Q2 FY2026
| Quarter | Revenue | Net Profit | OPM | NPM | EPS | Int. Cover |
|---|---|---|---|---|---|---|
| Q2 FY2027 | ₹1794 Cr | ₹388 Cr | 27.87% | 21.63% | ₹31.07 | Negligible |
| Q1 FY2027 | ₹1626 Cr | ₹334 Cr | 23.31% | 20.56% | ₹26.75 | 141.5x |
| Q4 FY2026 | ₹1422 Cr | ₹267 Cr | 20.26% | 18.76% | ₹21.35 | 148.1x |
| Q3 FY2026 | ₹1375 Cr | ₹274 Cr | 24.64% | 19.91% | ₹21.91 | 71.3x |
| Q2 FY2026 | ₹1354 Cr | ₹260 Cr | 21.04% | 19.22% | ₹20.83 | 101.5x |
| Q1 FY2026 | ₹1303 Cr | ₹255 Cr | 23.80% | 19.60% | ₹20.44 | 64.0x |
Momentum score, 1-year chart, moving averages, support and resistance.
Turnaround stage, and how each measure moved over 3 years against the company's own range.
Order wins, capex, pledges, rating actions and every material filing.
Management guidance, Q&A highlights and whether they delivered what they said.
The earnings call read across investor dimensions.
Promoter, FII and mutual fund holding, and what changed this quarter.
Similar-size peers in Pharmaceuticals
Compare with peers →Ajanta Pharma Limited, together with its subsidiaries, a pharmaceutical formulation company that develops, manufactures, and markets specialty pharmaceutical finished dosages. The company offers chronic and acute therapies; branded generic products; and a range of dosage forms, including tablets, capsules, injectables, inhalers, ointments, creams, and liquids. It also serves various therapeutic areas comprising cardiology, dermatology, ophthalmology, and pain management. The company operates in India, Africa, Asia, the United States, and internationally. Ajanta Pharma Limited was founded in 1973 and is headquartered in Mumbai, India.
Note: This comprehensive analysis combines technical data, fundamental data, and investment thesis. Always do your own research and consider your personal risk tolerance before investing.